Chicago

A blood-based test for colorectal cancer screening using a miRNA panel

Diagnostic biological tests/assays

Colorectal cancer (CRC) is the third leading cause of cancer and cancer-related death in the western world. In general this cancer develops slowly over the years from a small polyp up to a full metastatic cancer.  Early detection guarantees an excellent prognosis with survival of over 95%.  CRC screening has been shown to save lives and is highly cost effective.  Several strategies have been developed for CRC screening.

Proof of Concept Gap Funding Information Sessions • September 5th • 9AM to 12PM

Date: 
09/05/2012 - 9:00am - 12:00pm

The Office of Technology Management will be hosting two walk-in information sessions on the 2012 Proof of Concept (POC) Gap Funding Initiative for UIC faculty members interested in learning more about the POC program and the process for submitting proposals for POC grants.  The POC Initiative is a novel, grant funding program aimed at helping to reduce the technical or commercial risks related to UIC inventions and improve the chances that these inventions can become successfully commercialized.

2012 Proof of Concept Gap Funding Initiative: Second Round Call for Proposals

The Office of Technology Management is pleased to announce that it is now accepting Pre-Proposal Applications for the Second Round of the 2012 Proof of Concept Gap Funding Initiative.

 

To learn more about the Proof of Concept Gap Funding Initiative and to download information and application materials,

please click on the link below.

 

Chicago Health Technology & Health 2.0 Conference

Date: 
09/28/2012 - 09/29/2012

The Department of Defense: A Researcher’s Primer

Date: 
10/18/2012

Date:

•  Thursday, October 18, 2012

 

Location:

Novel Compounds for Multidrug-Resistant Anti-tuberculosis Agents

TherapeuticTherapeutic

Tuberculosis (TB) is a bacterial infection which primarily affects the lungs and central nervous system.  One third of the world's population is infected with the bacteria Mycobacterium tuberculosis, the causative agent of TB. There are approximately 500,000 cases of drug-resistant TB reported annually, 6.6% of which are extensively drug resistant.  To make matters worse, the number of annual TB cases is increasing due to population growth, along with the frequency of multidrug resistant TB (MDR-TB).

UIC Center for Cardiovascular Research (CCVR) Research Day

Date: 
08/07/2012

Join the UIC Center for Cardiovascular Research (CCVR) in celebrating     Research Day 2012!

 

Ceremonies kick off at 9:00AM with welcoming remarks followed by a Keynote Lecture titled "Metabolic Remodeling and Heart Failure" to be delivered by Dr. E. Douglas Lewandowski, Director of the UIC Center for Cardiovascular Research.

Evidence Based Treatment of Behavioral Symptoms of Dementia - Mobile App

Applications

Researchers at the University of Illinois at Chicago have developed a downloadable digital application (App) that is designed to aid clinicians and dementia care professionals in behavioral management of dementia in older adults. This App is an evidence based treatment algorithm that is designed to be downloaded to iOS and Android devices as a portable aid to clinicians in determining appropriate treatment options for those affected by dementia. Specifically, the App takes the user through a series of questions based on the behavior of the patient in order to determine treatment options.

Midwest Clean Tech 2012

Date: 
09/12/2012

 

Novel Molecular Mechanism of c-Src Regulation

Therapeutic
Src family kinases (SFKs) are associated with normal cellular homeostasis and their activity is elevated in some pathological conditions such as cancer and acute inflammation. In many human cancers, SFKs have been found to be overactive and transforming. In addition, elevated SFK activity is associated with tumor growth, survival, migration, and metastasis. Recent clinical trials have used SFK inhibitors in the treatment of breast canser and non-small cell lung cancer.
print